⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
OLMA News
Olema Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
OLMA
Olema Oncology Appoints Prakash Raman, Ph.D., to Board of Directors
globenewswire.com
OLMA
Olema Oncology to Present Initial Clinical Data for OP-3136 at the 2026 ASCO Annual Meeting
globenewswire.com
OLMA
Olema Oncology Announces Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
globenewswire.com
OLMA
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
OLMA
Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
globenewswire.com
OLMA
Form 8-K
sec.gov
OLMA
Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
globenewswire.com
OLMA
Olema Pharmaceuticals, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – OLMA
businesswire.com
OLMA
Olema Pharmaceuticals, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – OLMA
businesswire.com
OLMA